Haydar Alturaihi

554 total citations
10 papers, 464 citations indexed

About

Haydar Alturaihi is a scholar working on Immunology, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Haydar Alturaihi has authored 10 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 3 papers in Molecular Biology and 2 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Haydar Alturaihi's work include Immune Response and Inflammation (3 papers), T-cell and B-cell Immunology (3 papers) and Pituitary Gland Disorders and Treatments (2 papers). Haydar Alturaihi is often cited by papers focused on Immune Response and Inflammation (3 papers), T-cell and B-cell Immunology (3 papers) and Pituitary Gland Disorders and Treatments (2 papers). Haydar Alturaihi collaborates with scholars based in Canada, France and Morocco. Haydar Alturaihi's co-authors include Ujendra Kumar, Heather L. Watt, Walid Mourad, Alessandra Baragli, Ali T. Abdallah, Michael P. Grant, B. Collier, P Jaquet, Aidan Ablona and Di Xue and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Allergy and Clinical Immunology and Journal of Neurochemistry.

In The Last Decade

Haydar Alturaihi

10 papers receiving 457 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haydar Alturaihi Canada 10 190 157 124 102 91 10 464
Kishore K. Murthy Canada 11 235 1.2× 26 0.2× 87 0.7× 51 0.5× 55 0.6× 17 506
Tomiaki Asai Japan 11 135 0.7× 78 0.5× 62 0.5× 15 0.1× 38 0.4× 20 483
Altan Atakan Özcan Türkiye 10 168 0.9× 58 0.4× 34 0.3× 285 2.8× 20 0.2× 36 744
Carla Carter United States 10 430 2.3× 309 2.0× 15 0.1× 65 0.6× 89 1.0× 10 819
Johan Jongsma Netherlands 8 128 0.7× 31 0.2× 65 0.5× 29 0.3× 41 0.5× 10 409
Denise Sickert Switzerland 9 103 0.5× 163 1.0× 24 0.2× 73 0.7× 21 0.2× 14 363
V. Bodart Canada 9 194 1.0× 89 0.6× 33 0.3× 45 0.4× 114 1.3× 9 523
Tadao Serikawa Japan 8 261 1.4× 289 1.8× 24 0.2× 35 0.3× 20 0.2× 8 682
Tatsuo Itakura United States 12 203 1.1× 36 0.2× 31 0.3× 104 1.0× 13 0.1× 21 463
Ben J. E. Raveney Japan 12 184 1.0× 420 2.7× 56 0.5× 21 0.2× 12 0.1× 21 711

Countries citing papers authored by Haydar Alturaihi

Since Specialization
Citations

This map shows the geographic impact of Haydar Alturaihi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haydar Alturaihi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haydar Alturaihi more than expected).

Fields of papers citing papers by Haydar Alturaihi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haydar Alturaihi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haydar Alturaihi. The network helps show where Haydar Alturaihi may publish in the future.

Co-authorship network of co-authors of Haydar Alturaihi

This figure shows the co-authorship network connecting the top 25 collaborators of Haydar Alturaihi. A scholar is included among the top collaborators of Haydar Alturaihi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haydar Alturaihi. Haydar Alturaihi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Alturaihi, Haydar, Ghada S. Hassan, Daniel Yacoub, et al.. (2014). Interaction of CD154 with different receptors and its role in bidirectional signals. European Journal of Immunology. 45(2). 592–602. 20 indexed citations
2.
Massoud, Amir Hossein, Di Xue, Fazila Chouiali, et al.. (2013). Dendritic cell immunoreceptor: A novel receptor for intravenous immunoglobulin mediates induction of regulatory T cells. Journal of Allergy and Clinical Immunology. 133(3). 853–863.e5. 119 indexed citations
3.
Fakhry, Youssef El, Haydar Alturaihi, Daniel Yacoub, et al.. (2012). Functional Interaction of CD154 Protein with α5β1 Integrin Is Totally Independent from Its Binding to αIIbβ3 Integrin and CD40 Molecules. Journal of Biological Chemistry. 287(22). 18055–18066. 25 indexed citations
4.
Nadiri, Amal, Maria J. Polyak, Haydar Alturaihi, et al.. (2011). CD40 translocation to lipid rafts: Signaling requirements and downstream biological events. European Journal of Immunology. 41(8). 2358–2367. 23 indexed citations
5.
Fakhry, Youssef El, et al.. (2009). Critical role of lipid rafts in CD154‐mediated T cell signaling. European Journal of Immunology. 40(3). 770–779. 16 indexed citations
6.
Grant, Michael P., et al.. (2008). Cell Growth Inhibition and Functioning of Human Somatostatin Receptor Type 2 Are Modulated by Receptor Heterodimerization. Molecular Endocrinology. 22(10). 2278–2292. 91 indexed citations
7.
Baragli, Alessandra, Haydar Alturaihi, Heather L. Watt, Ali T. Abdallah, & Ujendra Kumar. (2007). Heterooligomerization of human dopamine receptor 2 and somatostatin receptor 2. Cellular Signalling. 19(11). 2304–2316. 113 indexed citations
8.
How, Jonathan P., et al.. (2006). β‐Amyloid increases somatostatin expression in cultured cortical neurons. Journal of Neurochemistry. 101(3). 664–673. 24 indexed citations
9.
Rivera, Juan, Haydar Alturaihi, & Ujendra Kumar. (2005). Differential regulation of somatostatin receptors 1 and 2 mRNA and protein expression by tamoxifen and estradiol in breast cancer cells.. Journal of Carcinogenesis. 4(1). 10–10. 18 indexed citations
10.
Watt, Heather L., Traian Sulea, Nabil G. Seidah, et al.. (2004). Prosomatostatin is proteolytically processed at the amino terminal segment by subtilase SKI-1. Regulatory Peptides. 120(1-3). 133–140. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026